Myrrh's Role in Breast Cancer Treatment
Author Information
Author(s): Shams Anwar MD, MSc, PhD, Alzahrani Abdullah Ahmed, Ayash Taghreed A MSc, PhD, Tamur Shadi MD, FRCPC, FAAP, AL-Mourgi Majed MD, FRCS, FCCP, FACS
Primary Institution: Taif University
Hypothesis
Can myrrh bioactive extracts serve as effective therapeutic agents in treating breast cancer?
Conclusion
Myrrh extracts may help block breast cancer tumorigenesis by targeting specific genes involved in cancer progression.
Supporting Evidence
- Myrrh's active components regulate genes involved in breast cancer pathogenesis.
- High expression of PTGS2, EGFR, ESR2, JUN, and MMP2 is linked to aggressive breast cancer subtypes.
- Patients with elevated expression of the gene signature have poor survival outcomes.
- Myrrh extracts have shown anti-cancer effects in various studies.
- Network pharmacology identified myrrh as a potential therapeutic candidate for breast cancer.
Takeaway
Myrrh, a natural substance, might help fight breast cancer by affecting certain genes that make the cancer grow.
Methodology
The study used network pharmacology and bioinformatics tools to analyze gene expression profiles and interactions related to myrrh's effects on breast cancer.
Potential Biases
Potential biases in data interpretation due to reliance on bioinformatics tools and existing datasets.
Limitations
Further experimental validation is needed to confirm the findings and explore the precise mechanisms of myrrh's action.
Participant Demographics
The study analyzed data from 5696 breast cancer patients across various molecular subtypes.
Statistical Information
P-Value
p<0.00001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website